Výsledky vyhledávání - "Sergey Meresiy"

Analysis of the Mortality of Russian Patients With Chronic Myeloid Leukemia in the Multicenter EUTOS ELN Population-based Study (EUTOS-PBS)

Autor: Olga Senderova, Ekatarina Yu. Chelysheva, Maria V. Galayko, Alexandr S. Luchinin, Anna G. Turkina, Hunan Julhakyan, L V Gavrilova, Anton Kulikovsky, Valentina Pepeliaeva, Olga V. Lazareva, Sergey Meresiy, Olga Yu. Vinogradova, Galina I. Milutina, Lyudmila B. Avdeeva, Sergey M. Kulikov, Elena B. Dasheeva

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 20:e328-e335

Russia took part in the multicenter population-based study (Europe) and included 6.8% adult patients with newly diagnosed chronic myeloid leukemia (CML). The objective of this study was to analyze the mortality in the Russian cohort of patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2119972ab36a62875942888051d98010
https://doi.org/10.1016/j.clml.2020.02.004

Zobrazit plný text záznamu

Analysis of Mortality of the Multicenter Eutos Eln Population-Based Study (EUTOS-PBS) in Russian Patients with Chronic Myeloid Leukemia

Autor: Hunan Julhakyan, Galina I. Milutina, Oleg Shukhov, Lubov Gavrilova, Valentina Pepeliaeva, Olga Vinogradova, Alexander S. Luchinin, Anton Kulikovskiy, Lubov Avdeeva, Maria V. Galayko, Sergey Meresiy, Ekaterina Chelysheva, Olga Senderova, Sergey M. Kulikov, Anna G. Turkina, Elena B. Dasheeva, Olga V. Lazareva

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 19:S298-S299

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2fbbb5ad4ea2509e119b9f505c82492
https://doi.org/10.1016/j.clml.2019.07.252

Zobrazit plný text záznamu

On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study

Autor: Galina I. Milutina, Ekaterina Chelysheva, Sergei M. Kulikov, Valentina Pepeliaeva, L B Avdeeva, Anton Kulikovsky, Lubov Gavrilova, Olga Vinogradova, Sergey Meresiy, Dolgorzhap Dasheeva, Olga V. Lazareva, Alexander S. Luchinin, Anna G. Turkina, Olga Senderova

Publikováno v: Blood. 134:5902-5902

Background: A success of the tyrosine kinase inhibitors (TKI) therapy in patients (pts) with chronic myeloid leukemia (CML) allowed to set a new goal: a treatment-free remission (TFR). A stable and long-lasting deep molecular response (DMR) is requir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5b90d338bacb27a4741ee02bea1b161
https://doi.org/10.1182/blood-2019-131430

Zobrazit plný text záznamu

Effect of Eculizumab on Physician-Reported Symptoms in the Russian Cohort of the Paroxysmal Nocturnal Hemoglobinuria (PNH) International Registry

Publikováno v: Blood. 124:5163-5163

Background: Paroxysmal nocturnal hemoglobinuria is a rare clonal hematopoietic stem cell disease that can lead to life-threatening complications including thrombotic events (TE), chronic kidney disease (CKD) and pulmonary hypertension. In 2011 the In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::910d59eac2ef9326e0eabf5c94a32a55
https://doi.org/10.1182/blood.v124.21.5163.5163

Zobrazit plný text záznamu

Data From The Russian Cohort Of The International Disease Registry For Paroxysmal Nocturnal Hemoglobinuria (PNH)

Publikováno v: Blood. 122:4866-4866

Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematopoietic stem cell disease that can lead to life-threatening complications including thrombotic events (TE), chronic kidney disease (CKD) and pulmonary hypertension. An internation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b88ec13599bbbae11a3407a5049249d
https://doi.org/10.1182/blood.v122.21.4866.4866

Zobrazit plný text záznamu

High Incidence of Primary Resistance to Imatinib in the Group of Ph-Negative BCR-ABL-positive CML Patients

Autor: Tatyana Riger, Larisa Fechina, Yulia Gryaznova, Marina Shumkova, Bulat Bakirov, Alexander Popov, Grigory Tsaur, Irina Krylova, Ekaterina Nokhrina, Egor Shorikov, Leonid Saveliev, Anna Ivanova, Olga Plekhanova, Sergey Meresiy

Publikováno v: Publons

Abstract 3772 Background. Around 1–2% of the CML patients do not have t(9;22)(q34;q11) detectable by conventional cytogenetics, but carry BCR-ABL fusion revealed by fluorescence in situ hybridization (FISH) and/or reverse-transcriptase PCR (RT-PCR)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07668a137bf4b7c56680d4a0f27bd9d7
https://doi.org/10.1182/blood.v118.21.3772.3772

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání